‘What is happening is morally and medically appalling’
Drugs given that ‘deform’ genitalia and cause bleeding are simply dangerous and absurd
- Jamie Reed worked at The Washington University Transgender Center
- She says what is being done is causing ‘permanent harm’ to vulnerable kids
- Reed says she can’t sit back and watch the situation go on any longer
By JEN SMITH, CHIEF REPORTER FOR DAILYMAIL.COM – Daily Mail
PUBLISHED: 13:17 EST, 9 February 2023 | UPDATED: 14:18 EST, 9 February 2023
A whistleblower is speaking out after spending four years working at a trans clinic for kids, where she claims teenagers are prescribed harmful drugs they have no understanding of, after being coerced into transitioning because it’s deemed trendy.
Jamie Reed worked at The Washington University Transgender Center at St. Louis Children’s Hospital and was responsible for patient intake between 2018 and November 2022.
In an article for The Free Press today, she says she took the job with the intention of ‘saving’ trans kids, but that she believes what is happening amounts to ‘permanent harm’ on young, vulnerable children.
After four years, she says she became convinced the clinics were harming kids and families, whose understanding of the realities of the medical side-effects involved was scarily poor.
Jamie Reed worked at The Washington University Transgender Center at St. Louis Children’s Hospital between 2018 and November 2022
Doctors acted as though they were more entitled to make decisions than parents, says Reed, and only one parent’s consent was required in cases involving minors.
Reed cites examples of a 17-year-old girl’s birth canal allegedly being ‘ripped open’ when she had sex while taking testosterone to transition to male, unaware that the drug would cause her to bleed extensively through her clothes if she had intercourse.
In other scenarios, she claims teenage girls were terrified when their clitorises turned into micro-penises while they took the drugs.
Some psychiatrically ‘disturbed’ children from juvenile detention centers were also presented because they had ‘at some point’ expressed an interest in changing gender.
Among those patients, according to Reed, was a boy who’d been sexually abusing dogs.
‘Somewhere along the way, he expressed a desire to become female, so he ended up being seen at our center.
‘The way the American medical system is treating these patients is the opposite of the promise we make to “do no harm.”
‘Instead, we are permanently harming the vulnerable patients in our care… what is happening to scores of children is morally and medically appalling.’
She describes seeing a sudden, sharp uptick in the number of young girls ‘demanding testosterone’, sometimes presenting themselves as ‘clusters’ from the same schools.
Reed perceived a ‘lack of formal protocol’ at the center, and that doctors ignored the fact young girls lied about having other illnesses and prescribed them hormones.
She reveals that in order for a young girl to start transitioning to male, all she needed to do was see a clinic-recommended therapist once or twice and obtain a letter of support for their decision.
That therapist was often given a template for the letter that was written by the clinic, according to Reed.
‘Frequently, our patients declared they had disorders that no one believed they had.
‘We had patients who said they had Tourette syndrome (but they didn’t); that they had tic disorders (but they didn’t); that they had multiple personalities (but they didn’t).
‘The doctors privately recognized these false self-diagnoses as a manifestation of social contagion,’ Reed says.
‘They even acknowledged that suicide has an element of social contagion. But when I said the clusters of girls streaming into our service looked as if their gender issues might be a manifestation of social contagion, the doctors said gender identity reflected something innate.’
Reed says she was hesitant to raise her concerns because anyone who did was deemed a ‘transphobe’.
She describes warning young girls about the lasting physical effects of taking testosterone hormones – including sterility – but that they didn’t understand the seriousness of what they were doing.
‘Teenagers are simply not capable of fully grasping what it means to make the decision to become infertile while still a minor,’ she writes.
‘The center downplayed the negative consequences, and emphasized the need for transition.’
She lists one example of a young boy who wanted to transition to female. Neither he nor his family ‘understood’ the severe effects of Bicalutamide, one of the prescribed drugs he received.
Bicalumatide is predominantly used to treat prostate cancer and can lead to liver toxicity – which is what happened in this child’s case.
It is frequently prescribed as a feminizing trans drug.
In this child’s case, he ended up in the hospital. His parents threatened to sue, according to Reed, who had told colleagues the child wasn’t ready to undergo therapy because neither he nor his family fully grasped the drug’s side-effects
Another teenager who was taking testosterone to transition from female to male was unaware that the hormone caused her vaginal tissue to thin.
After having sex, she began bleeding uncontrollably, soaking through her jeans and a towel, before having to go to the emergency room where she was sedated and underwent vaginal surgery.
‘Clinics like the one where I worked are creating a whole cohort of kids with atypical genitals – and most of these teens haven’t even had sex yet.
‘They had no idea who they were going to be as adults. Yet all it took for them to permanently transform themselves was one or two short conversations with a therapist,’ Reed writes.
She also includes emails from concerned parents revoking their consent for the medications and procedures, after their kids turned into ‘shells’ of themselves.
‘Who knows if it’s because of the hormone blockers or the other medications. I revoke my consent. I want the hormone blocker removed,’ one mother wrote.
Reed also describes a terrifying lack in consultation with both parents.
She gives the example of a family where the father and mother were in the midst of a divorce and the mother was championing that their 11-year-old daughter be given puberty blockers to allow her transition to male.
Reed said she found the mother ‘disturbing’ and thought the child didn’t meet the initial criteria to transition when she interviewed them.
Weeks later, the mother returned to the clinic with a different set of answers for Reed’s questions, and her colleagues approved the girl for transition.
A judge then sided with the mother in court, allowing the child to move forward, despite her father’s strong protest against it.
In 2019, Reed said she started noticing a growing number of patients deciding not to go through with transition, or deciding to return to the gender they had been previously.
She and her colleague started collating information about those patients with the assumption that the doctors would want to know about their change of heart.
‘We thought the doctors would want to collect and understand this data in order to figure out what they had missed.
‘We were wrong. One doctor wondered aloud why he would spend time on someone who was no longer his patient.’
She and her colleague started a ‘red flag list’ to keep track of kids who had changed their minds.
The hospital did not respond to Reed’s allegations when contacted by DailyMail.com.
Reed transferred from the transgender center to a different department in November 2022.
She says the doctors at the hospital treat the issue of transitioning among teens as an ‘experiment’.
‘Experiments are supposed to be carefully designed. Hypotheses are supposed to be tested ethically.
‘The doctors I worked alongside at the Transgender Center said frequently about the treatment of our patients: “We are building the plane while we are flying it.”
‘No one should be a passenger on that kind of aircraft.’
What is Bicalutamide?
Bicalutamide works by blocking the effects of the male hormone androgen.
It is sold under the brand name Casodex.
The drug was approved by the Food and Drug Administration in 2008 as a treatment for prostate cancer.
It blocks receptors in the central nervous and male reproductive systems responsible for producing androgen.
The hormone helps promote the growth of prostate cancer cells, and cutting them off can stop the disease from spreading.
In recent years, the drug has also started to be used off-label for transgender children and teens.
When used in this way, bicalutamide is sometimes called a ‘puberty blocker’.
By stopping the release of androgen in a young person, the drugs can also block biological boys from becoming men.
Androgen is a key hormone during puberty that leads to a deep voice, Adam’s apple, facial and body hair and the growth of the penis and testicles.
Similar blockers also exist for women, preventing the development of breasts and other female features.
The drugs were safe for use and had to undergo a rigorous pre-approval process.
But, there is little information on their long-term physical and psychological effects when used in children.
The effects are not thought to be permanent, but it takes years for the body to return to previous hormone secretion levels after coming off of the drugs.